Indonesian firms joining forces to produce virus test kits locally
INDONESIA’S unicorns and start-ups have joined forces to produce test kits locally, a move that may help President Joko ‘Jokowi’ Widodo achieve his target of doubling testing capacity for Covid19 as cities across the world’s fourth most populous country gradually lift restrictions.
A unicorn refers to any tech startup that reaches $1 billion in market value.
Jakarta-based East Ventures, which has a portfolio of start-up companies, recently raised 10 billion rupiah ($705,000) to develop prototypes of locally-made polymerase chain reaction (RT-PCR) test kits.
Unicorns PT Tokopedia, an ecommerce platform, and PT Traveloka Indonesia, an airline ticketing and hotel booking company, were among several companies and individuals contributing monies to the Indonesia Pasti Bisa (Indonesia Can Do It) initiative, which comes under the auspices of Indonesia’s Agency for the Assessment and Application of Technology (BPPT).
Jakarta-based genomics technology start-up Nusantics was appointed by the government to design the test kit prototypes, which it did for free.
The firm’s CEO Sharlini Eriza Putri told The Straits Times on Tuesday that the prototypes were validated by laboratories across Indonesia in May as being equivalent to those imported.
These laboratories comprise those appointed by the government to carry out PCR tests.
State-owned pharmaceutical company PT Bio Farma has produced and distributed 100,000 test kits based on the Nusantics prototypes.
BPPT deputy chief Soni Solistia Wirawan said the test kits are more suited to local needs as they are being produced based on samples taken from coronavirus patients in Indonesia.
The move to produce test kits locally is to reduce reliance on imports.
Indonesia had orders of test kits made overseas cancelled and in some instances, hijacked by other countries, as it grappled with the coronavirus which has infected more than 33,000 people and killed over 1,900.
The funds raised in the initiative were used to procure raw materials for the prototypes, manufacture the final test kits as well as pay for transporting them to laboratories across Indonesia.
Nusantics’ Sharlini said: “The challenge going forward is to always monitor the virus mutation, to regularly check if the test kits need updating.”
Cities across Indonesia have moved to ease restrictive measures three months after the first local coronavirus case was detected.
Jakarta, the epicentre of infections in the country, entered a “transition phase” on June 5 with places of worship and workplaces allowed to open amid strict health guidelines, which include operating at only 50 per cent capacity.
Shopping centres in the city are slated to open in mid-June.
Jokowi had earlier underlined the need to raise testing capacity to 20,000 tests a day, after Indonesia achieved early this month its target of 10,000 tests a day.
The president also stressed that aggressive contact tracing measures using communication technology – such as the mobile GPS – must be introduced quickly.
Before this month, Indonesia had one of the lowest testing rate among countries with a population of 50 million or more, according to pandemic data site Worldometer.
But the country of 270 million is no longer near the bottom of the list, having achieved a test rate of 1,570 for every one million population, Worldometer data showed.